Evidence map›Paper›PMID 32737473›Full record

ArticleNature methods2020

Supervised enhancer prediction with epigenetic pattern recognition and targeted validation.

Anurag Sethi, Mengting Gu, Emrah Gumusgoz, Landon Chan, Koon-Kiu Yan, Joel Rozowsky, Iros Barozzi, Veena Afzal, Jennifer A Akiyama, Ingrid Plajzer-Frick and 15 more

Abstract read
In one paragraph

Article in Nature methods, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Anurag Sethi *Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-3295-3116
Mengting Gu *Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-1684-0146
Emrah GumusgozDepartment of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.
Landon ChanSchool of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Koon-Kiu YanDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-2337-485X
Joel RozowskyDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-3565-0762
Iros BarozziFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Veena AfzalFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Jennifer A AkiyamaFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Ingrid Plajzer-FrickFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Chengfei YanDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.
Catherine S NovakFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Momoe KatoFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Tyler H GarvinFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Quan PhamFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Anne HarringtonFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Brandon J MannionFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-1149-3790
Elizabeth A LeeFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Yoko Fukuda-YuzawaFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Axel ViselFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-4130-7784
Diane E DickelFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.ORCID http://orcid.org/0000-0001-5497-6824
Kevin Y YipDepartment of Computer Science, The Chinese University of Hong Kong, Hong Kong, China.ORCID http://orcid.org/0000-0001-5516-9944
Richard SuttonDepartment of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.
Len A PennacchioFunctional Genomics Department, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Mark GersteinDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA. mark@gersteinlab.org.ORCID http://orcid.org/0000-0002-9746-3719

Funding

Generation of an In Vivo Human Genome Transcriptional Enhancer DatasetR01HG003988 · NHGRI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Len Alexander Pennacchio · 2006 to 2026
$24.1M
Center for Mammalian Regulatory GenomicsU54HG006997 · NHGRI · LUDWIG INSTITUTE FOR CANCER RES LTD · PI REN, BING · 2012 to 2016
$14.3M
EDAC: ENCODE Data Analysis CenterU24HG009446 · NHGRI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GERSTEIN, MARK BENDER, WENG, ZHIPING · 2017 to 2022
$10.4M
In Vivo Characterization of Major ENCODE-Predicted Classes of Noncoding ElementsUM1HG009421 · NHGRI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PENNACCHIO, LEN ALEXANDER, VISEL, AXEL · 2017 to 2021
$6.8M
Genome-Wide Resources for Transcriptional Enhancers Active in the Human HeartR24HL123879 · NHLBI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PENNACCHIO, LEN ALEXANDER, VISEL, AXEL · 2015 to 2019
$3.9M
NHGRI NIH HHS R01 HG003988NHGRI NIH HHS U24 HG009446NHGRI NIH HHS U54 HG006997NHGRI NIH HHS UM1 HG009421NHLBI NIH HHS R24 HL123879
6 · The paper itself

Abstract

Enhancers are important non-coding elements, but they have traditionally been hard to characterize experimentally. The development of massively parallel assays allows the characterization of large numbers of enhancers for the first time. Here, we developed a framework using Drosophila STARR-seq to create shape-matching filters based on meta-profiles of epigenetic features. We integrated these features with supervised machine-learning algorithms to predict enhancers. We further demonstrated that our model could be transferred to predict enhancers in mammals. We comprehensively validated the predictions using a combination of in vivo and in vitro approaches, involving transgenic assays in mice and transduction-based reporter assays in human cell lines (153 enhancers in total). The results confirmed that our model can accurately predict enhancers in different species without re-parameterization. Finally, we examined the transcription factor binding patterns at predicted enhancers versus promoters. We demonstrated that these patterns enable the construction of a secondary model that effectively distinguishes enhancers and promoters.

Indexed as

AnimalsCell LineDrosophilaEpigenesis, GeneticHistonesHumansMiceMice, TransgenicPattern Recognition, AutomatedReproducibility of ResultsHistones

Identifiers

PMID32737473
PMCPMC8073243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.